NCT03899428
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Humanity & Health Research Centre Hong Kong, Hong Kong SAR
Clinical trial condition
Liver Neoplasms
Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.
1,743 public trials
463 recruiting studies
Liver Neoplasms trial results
NCT03612726
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Beijing 302 Hospital Beijing, China
- Humanity & Health Medical Group Limited Hong Kong
- Tokyo University Tokyo, Japan
NCT06883539
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +31 more
- Locations
-
- China Medical University Hospital Taichung, Taiwan
- National Cheng Kung University Hospital Tainan, Taiwan
NCT06864221
- Conditions
- Adenocarcinoma, Biomarkers, Carcinoma, +13 more
- Locations
-
- Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
NCT06371157
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Henan Cancer Hospital Zhengzhou, Henan, China
- Hunan Cancer Hospital Changsha, Hunan, China
- Zhongda Hospital Southeast University Nanjing, Jiangsu, China
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
NCT05489289
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China
NCT04510129
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +63 more
- Locations
-
- Curebase San Francisco, California, United States
NCT04745390
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- London Regional Cancer Program London, Ontario, Canada
NCT03895359
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- London Health Sciences Centre, London Regional Cancer Program London, Ontario, Canada
Recruiting
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
NCT06870942
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China